Laura Porter

4.9k total citations
12 papers, 689 citations indexed

About

Laura Porter is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Laura Porter has authored 12 papers receiving a total of 689 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Laura Porter's work include Global Cancer Incidence and Screening (2 papers), Iron Metabolism and Disorders (2 papers) and Erythropoietin and Anemia Treatment (2 papers). Laura Porter is often cited by papers focused on Global Cancer Incidence and Screening (2 papers), Iron Metabolism and Disorders (2 papers) and Erythropoietin and Anemia Treatment (2 papers). Laura Porter collaborates with scholars based in United States, Switzerland and Italy. Laura Porter's co-authors include Alvaro Leone, P. S. Steeg, Ariella M. Rosengard, Julia Bohlius, Roberto Castelli, Kari Bohlke, Alejandro Lazo‐Langner, Gianluca Trifirò, Benjamin Djulbegović and Tiffany Tanaka and has published in prestigious journals such as Journal of Clinical Oncology, Biology of Reproduction and Patient Education and Counseling.

In The Last Decade

Laura Porter

12 papers receiving 671 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Porter United States 8 414 206 179 119 117 12 689
Eddie Reed United States 13 323 0.8× 248 1.2× 326 1.8× 39 0.3× 124 1.1× 25 791
ES Newlands United Kingdom 16 336 0.8× 96 0.5× 258 1.4× 95 0.8× 120 1.0× 38 1.0k
Jacqueline Ming Liu Taiwan 15 192 0.5× 85 0.4× 361 2.0× 28 0.2× 177 1.5× 26 825
G. Lelli Italy 13 167 0.4× 78 0.4× 368 2.1× 49 0.4× 223 1.9× 46 876
Nektaria Makrilia Greece 15 280 0.7× 73 0.4× 325 1.8× 16 0.1× 287 2.5× 23 1.0k
Carsten‐Oliver Schulz Germany 13 235 0.6× 36 0.2× 283 1.6× 170 1.4× 55 0.5× 20 554
Takuro Nishikawa Japan 11 221 0.5× 62 0.3× 240 1.3× 118 1.0× 77 0.7× 60 677
Carla Cavaliere Italy 20 353 0.9× 54 0.3× 280 1.6× 29 0.2× 368 3.1× 52 952
Xueying Wang China 8 260 0.6× 37 0.2× 212 1.2× 35 0.3× 95 0.8× 29 683
Suzanne M. Fields United States 12 167 0.4× 49 0.2× 385 2.2× 33 0.3× 143 1.2× 15 610

Countries citing papers authored by Laura Porter

Since Specialization
Citations

This map shows the geographic impact of Laura Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Porter more than expected).

Fields of papers citing papers by Laura Porter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Porter. The network helps show where Laura Porter may publish in the future.

Co-authorship network of co-authors of Laura Porter

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Porter. A scholar is included among the top collaborators of Laura Porter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Porter. Laura Porter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Porter, Laura, Karyn A. Goodman, Josh Mailman, & Wendy S. Garrett. (2023). Patient Advocates and Researchers as Partners in Cancer Research: A Winning Combination. American Society of Clinical Oncology Educational Book. 43(43). e100035–e100035. 7 indexed citations
2.
Porter, Laura, et al.. (2021). A delayed path to diagnosis: Findings from young-onset colorectal cancer patients and survivors.. Journal of Clinical Oncology. 39(3_suppl). 5–5. 5 indexed citations
3.
Porter, Laura, et al.. (2021). Young-onset colorectal: Emotional and psychosocial effects on patients, survivors, and caregivers.. Journal of Clinical Oncology. 39(15_suppl). 3592–3592. 1 indexed citations
4.
Porter, Laura, et al.. (2021). Young-onset colorectal cancer treatment side effects: Infertility, sexual dysfunction, and quality-of-life outcomes.. Journal of Clinical Oncology. 39(15_suppl). 3587–3587. 1 indexed citations
5.
Bohlius, Julia, Kari Bohlke, Roberto Castelli, et al.. (2019). Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update. Blood Advances. 3(8). 1197–1210. 112 indexed citations
6.
Randazzo, Dina, James E. Herndon, Mary Lou Affronti, et al.. (2019). QOLP-29. MINDFULNESS MEDITATION PRACTICE IN MALIGNANT GLIOMA PATIENTS THROUGHOUT CONCOMITANT RADIATION AND TEMOZOLOMIDE: A FEASIBILITY STUDY. Neuro-Oncology. 21(Supplement_6). vi204–vi204. 1 indexed citations
7.
Bohlius, Julia, Kari Bohlke, Roberto Castelli, et al.. (2019). Management of Cancer-Associated Anemia With Erythropoiesis-Stimulating Agents: ASCO/ASH Clinical Practice Guideline Update. Journal of Clinical Oncology. 37(15). 1336–1351. 87 indexed citations
8.
Enzinger, Andrea C., Nadine J. McCleary, Laura Porter, et al.. (2017). A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy. Patient Education and Counseling. 100(8). 1527–1536. 14 indexed citations
9.
Sanborn, Barbara M., et al.. (1991). Regulation of Androgen Receptor mRNA in Rat Sertoli and Peritubular Cells1. Biology of Reproduction. 45(4). 634–641. 39 indexed citations
10.
Leone, Alvaro, et al.. (1991). Identification of a second human nm23 gene, nm23-H2.. PubMed. 51(1). 445–9. 327 indexed citations
11.
King, C. Richter, Sandra M. Swain, Laura Porter, et al.. (1989). Heterogeneous expression of erbB-2 messenger RNA in human breast cancer.. PubMed. 49(15). 4185–91. 56 indexed citations
12.
Borrello, Ivan, et al.. (1989). Ligand-independent tyrosine phosphorylation of EGF receptor and the erbB-2/neu proto-oncogene product is induced by hyperosmotic shock.. PubMed. 4(1). 13–8. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eddie Reed Breakdown of academic impact, for papers by ES Newlands Breakdown of academic impact, for papers by Jacqueline Ming Liu Breakdown of academic impact, for papers by G. Lelli Breakdown of academic impact, for papers by Nektaria Makrilia Breakdown of academic impact, for papers by Carsten‐Oliver Schulz Breakdown of academic impact, for papers by Takuro Nishikawa Breakdown of academic impact, for papers by Carla Cavaliere Breakdown of academic impact, for papers by Xueying Wang Breakdown of academic impact, for papers by Suzanne M. Fields
Rankless by CCL
2026